Gene · 3036
Papers4,320
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 4,320
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanotransduction: Exploring New Therapeutic Avenues in Central Nervous System Pathology. | Front Neurosci | 2022 | 35573316 | PubTator, text mining | PubMed |
| Cryoballoon Ablation for Treatment of Atrial Fibrillation in a Chinese Population: Five-Year Outcomes and Predictors of Recurrence After a Single Procedure. | Front Cardiovasc Med | 2022 | 35571157 | PubTator, text mining | PubMed |
| Use of Hyperoncotic Human Albumin Solution in Severe Traumatic Brain Injury Revisited-A Narrative Review and Meta-Analysis. | J Clin Med | 2022 | 35566786 | PubTator, text mining | PubMed |
| Temporal Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients between 2004 and 2019. | Int J Environ Res Public Health | 2022 | 35564979 | PubTator, text mining | PubMed |
| 3D In Vitro Models: Novel Insights into Idiopathic Pulmonary Fibrosis Pathophysiology and Drug Screening. | Cells | 2022 | 35563831 | PubTator, text mining | PubMed |
| MicroRNA-145 Impairs Classical Non-Homologous End-Joining in Response to Ionizing Radiation-Induced DNA Double-Strand Breaks via Targeting DNA-PKcs. | Cells | 2022 | 35563814 | PubTator, text mining | PubMed |
| Disulfiram Exerts Antifibrotic and Anti-Inflammatory Therapeutic Effects on Perimysial Orbital Fibroblasts in Graves' Orbitopathy. | Int J Mol Sci | 2022 | 35563653 | PubTator, text mining | PubMed |
| The EPH/Ephrin System in Bone and Soft Tissue Sarcomas' Pathogenesis and Therapy: New Advancements and a Literature Review. | Int J Mol Sci | 2022 | 35563562 | PubTator, text mining | PubMed |
| Quantification and Improvement of the Dynamics of Human Serum Albumin and Glycated Human Serum Albumin with Astaxanthin/Astaxanthin-Metal Ion Complexes: Physico-Chemical and Computational Approaches. | Int J Mol Sci | 2022 | 35563162 | PubTator, text mining | PubMed |
| Case Report: Reversal of Hyaluronic Acid Rectal Wall Infiltration with Hyaluronidase. | Front Oncol | 2022 | 35558509 | PubTator, text mining | PubMed |
| Influence of atrial fibrillation subtypes on anticoagulant therapy in a high-risk older population: the FAI project. | Aging Clin Exp Res | 2022 | 35543807 | PubTator, text mining | PubMed |
| Hsa_circ_0003748 promotes disease progression in rheumatic valvular heart disease by sponging miR-577. | J Clin Lab Anal | 2022 | 35535387 | PubTator, text mining | PubMed |
| Network for network concept offers new insights into host- SARS-CoV-2 protein interactions and potential novel targets for developing antiviral drugs. | Comput Biol Med | 2022 | 35533462 | PubTator, text mining | PubMed |
| Gather wisdom to overcome barriers: Well-designed nano-drug delivery systems for treating gliomas. | Acta Pharm Sin B | 2022 | 35530155 | PubTator, text mining | PubMed |
| High Levels of PD-L1+ and Hyal2+ Myeloid-derived Suppressor Cells in Renal Cell Carcinoma. | J Kidney Cancer VHL | 2022 | 35528727 | PubTator, text mining | PubMed |
| Proteins in human body fluids contain in vivo antigen analog of the melibiose-derived glycation product: MAGE. | Sci Rep | 2022 | 35525899 | PubTator, text mining | PubMed |
| Efficacy and safety of anticoagulation in thyrotoxic atrial fibrillation: a systematic review and meta-analysis. | Endocr Connect | 2022 | 35521808 | PubTator, text mining | PubMed |
| Antithrombotic Therapy After Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation. | J Am Coll Cardiol | 2022 | 35512858 | PubTator, text mining | PubMed |
| Systematic Analysis of Chemokines Reveals CCL18 is a Prognostic Biomarker in Glioblastoma. | J Inflamm Res | 2022 | 35509325 | PubTator, text mining | PubMed |
| The emerging landscape of exosomal CircRNAs in solid cancers and hematological malignancies. | Biomark Res | 2022 | 35505392 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3036/papers?page=50